| Timeframe | Predicted Price | Past | Historical | Insight |
|---|---|---|---|---|
| Tomorrow | $184.31 ▼ -0.88% | Yesterday | $186.64 ▲ +0.37% | Tomorrow's Biogen Inc. Common Stock (BIIB) setup is anchored to $185.95 and targets $184.31 (-0.88%). The near-term read is downside; watch $191.53 / $180.37 because daily realized volatility is about 4.56%. |
Tomorrow's Biogen Inc. Common Stock (BIIB) setup is anchored to $185.95 and targets $184.31 (-0.88%). The near-term read is downside; watch $191.53 / $180.37 because daily realized volatility is about 4.56%. | ||||
| Week | $180.84 ▼ -2.75% | Last Week | $188.10 ▲ +1.16% | The 7-day Biogen Inc. Common Stock model moves from $188.10 to $180.84 (-2.75%). It gives downside momentum context for this stock, so breaks around $191.53 / $180.37 matter more than a single tick. |
The 7-day Biogen Inc. Common Stock model moves from $188.10 to $180.84 (-2.75%). It gives downside momentum context for this stock, so breaks around $191.53 / $180.37 matter more than a single tick. | ||||
| Month | $175.06 ▼ -5.86% | Last Month | $190.52 ▲ +2.46% | The 1-month Biogen Inc. Common Stock target is $175.06 (-5.86%), compared with the live reference near $185.95. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month Biogen Inc. Common Stock target is $175.06 (-5.86%), compared with the live reference near $185.95. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Year | $166.40 ▼ -10.51% | Last Year | $194.16 ▲ +4.42% | The 1-year Biogen Inc. Common Stock scenario points to $166.40 (-10.51%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year Biogen Inc. Common Stock scenario points to $166.40 (-10.51%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Years | $146.10 ▼ -21.43% | 5 Years Ago | $202.69 ▲ +9.00% | The 5-year Biogen Inc. Common Stock view is $146.10 (-21.43%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year Biogen Inc. Common Stock view is $146.10 (-21.43%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Indicator | Value | Signal |
|---|---|---|
| Price | $185.95 | Mid |
| Daily Change | +1.42% | Above |
| Volatility Cap | 20.0% | Mid |
| Confidence | 60% | Below |
| Data Source | nasdaq-screener | Mid |
| Current | $185.95 | Daily Change | +1.42% |
| Market Cap | $27.29B | Source | nasdaq-screener |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.